FDA Inspection 1160499 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on December 30, 2021 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 30, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Augusta, GA (United States)